Mass defect labeling and methods of use thereof
View Patent ↗Mass defect labeled peptides and methods of identifying peptides are provided. In particular, embodiments of the present disclosure include mass defect labels for polypeptides that include at least one cysteine and/or at least one tryptophan and methods of using the mass defect labels to identify polypeptides. One embodiment, among others, includes a mass defect labeled peptide including at least one cysteine residue labeled with 2,4-dibromo-acetanilide. Another embodiment, among others, includes a mass defect labeled peptide including at least one tryptophan residue labeled with 4,6-dibromo-2-trifluoromethylphenylsulfenyl chloride.
1. A peptide comprising:
a mass defect labeled peptide including at least one cysteine, wherein at least one of the cysteine residues are labeled with 2,4-dibromo-acetanilide.
2. The peptide of claim 1 , wherein the mass defect labeled peptide includes at least one tryptophan, wherein at least one of the tryptophan residues are labeled with 4,6-dibromo-2-trifluoromethylphenylsulfenyl chloride.
3. A method of identifying peptides comprising:
labeling at least one cysteine in a target peptide with a mass defect label, wherein the mass defect label is 2,4-dibromo-acetanilide;
introducing the target peptide to a mass spectrometry system; and
obtaining a mass spectrum of the target peptide.
4. The method of claim 3 , further comprising:
labeling at least one tryptophan in the target peptide with a mass defect label, wherein the mass defect label is 4,6-dibromo-2-trifluoromethylphenylsulfenyl chloride.
5. The method of claim 3 , wherein the mass spectrometry system is selected from an ion trap mass analyzer system (IT-MS), an ion cyclotron resonance mass analyzer system (ICR-MS), and an orbitrap system.
6. A peptide comprising:
a mass defect labeled peptide including at least one tryptophan, wherein at least one of the tryptophan residues are labeled with 4,6-dibromo-2-trifluoromethylphenylsulfenyl chloride.
7. A method of identifying peptides comprising:
labeling at least one tryptophan in a target peptide with a mass defect label, wherein the mass defect label is 4,6-dibromo-2-trifluoromethylphenylsulfenyl chloride;
introducing the target peptide to a mass spectrometry system; and
obtaining a mass spectrum of the target peptide.
8. The method of claim 7 , wherein the mass spectrometry system is selected from an ion trap mass analyzer system (IT-MS), an ion cyclotron resonance mass analyzer system (ICR-MS), and an orbitrap system.